StopDown
Funding · 10 February 2026CURAPOD₹20 CrWearable pain management devices

CuraPod raises ₹20 crore pre-Series A round

By · Editor ·

pre-Series AFounded 2022
  • CuraPod makes wearable medical devices for musculoskeletal pain relief
  • It raised ₹20 Cr ($2.2 Mn) from V3 Ventures, 3i Partners and Ideaspring Capital
  • The company targets 5X revenue growth and plans to enter Europe

What happened

  • CuraPod raised ₹20 Cr ($2.2 Mn) in a pre-Series A round.
  • The round was led by V3 Ventures, 3i Partners and Ideaspring Capital.
  • The funds will be used for product enhancements, marketplace sales and marketing.
  • CuraPod also plans to expand into gym, physio and sports medicine partnerships.
  • It will scale manufacturing and strengthen go-to-market operations.
  • The company is preparing to enter the Europe market.
  • CuraPod aims to build a broader portfolio of light therapy-based health solutions.

Why it matters

  • Healthtech funding and deal volumes have declined in India recently.
  • The Indian healthtech market is expected to cross $37 Bn by 2030.
  • The sector is shifting from episodic care to prevention, with startups like Ultrahuman and Noise selling smart wearables.
  • Eternal cofounder Deepinder Goyal is exploring a wearable device company called 'Temple' for brain monitoring.

The business

  • CuraPod manufactures a wearable medical device for musculoskeletal pain management.
  • The device is engineered and manufactured in India.
  • It uses medical-grade photobiomodulation technology (red light wavelengths).
  • The device works at the cellular level to reduce inflammation, improve circulation and support tissue repair.
  • Pain relief requires 30-60 minutes of daily use.
  • The device is FDA-registered and supports over 30 musculoskeletal conditions.
  • Conditions include back pain, neck pain, knee pain, joint disorders, muscle stiffness, sports injuries and chronic injuries.

The founders

Sri Velliyur

cofounder & CEO

Surya Prakash Maguluri

cofounder

Who put in money

In numbers

5Xrevenue growth target · next 12 months

What happens next

  • CuraPod will enhance its product and app.
  • It will expand marketplace sales and marketing.
  • It will partner with gyms, physiotherapists and sports medicine professionals.
  • It will scale manufacturing and go-to-market operations.
  • It is preparing to enter the Europe market.
  • It plans to build a broader portfolio of light therapy-based health solutions.

Words to know

pre-Series A
A funding round between seed and Series A, typically for startups that have proven their product but need capital to scale.
photobiomodulation
The use of red or near-infrared light to stimulate cellular repair and reduce inflammation.
FDA-registered
The device is listed with the US Food and Drug Administration, meaning it meets safety and effectiveness standards for medical devices.
musculoskeletal conditions
Disorders affecting muscles, bones, joints and connective tissues, such as back pain, arthritis and sports injuries.

The numbers around it

Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Pre-Series A: A pre-Series A round is money raised after a seed round and before a full Series A, so that a startup can reach the revenue, growth and retention Series A investors expect. In India such rounds commonly run from about ₹5 crore to ₹40 crore, and the label itself is informal.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Medical device vs wellness wearable: In India a health wearable is treated as a medical device when its maker says it can diagnose, monitor, treat or prevent a disease. A gadget sold only for general fitness or wellness sits outside those rules, but its claims are still policed by consumer law.

All startup news on 10 February 2026 →

Is this CURAPOD? Get your “Featured on StopDown” badge →